Entry into the cell cycle of dormant hematopoietic progenitors appears to be regulated by multiple synergistic factors, including interleukin-6 (IL-6). granulocyte colony-stimulating factor (G-CSF), IL-11, and the ligand for c-kit, which is also known as steel factor (SF). We have tested the effects of these and other hematopoietic factors on the proliferation of partially enriched dormant murine progenitors in the presence and absence of serum. In serum-containing cultures, SF and IL-11 interacted to support the formation of multilineage colonies; the level of colony formation was comparable with the colony formation supported by other effective two-factor combinations. In serum-free cultures, colony formation supported by two factors was significantly less than that in N THE STEADY STATE bone marrow, most hemato-I poietic stem cells are in a quiescent state termed Go. In this state, they divide infrequently to yield actively proliferating multipotential progenitors. During regeneration from marrow aplasia, the stem cells are activated to divide more frequently. Several cytokines appear to be involved in the process of activation and regulation of the proliferation of the stem cells and their progeny. Interleukin-3 (IL-3) supports the proliferation of multipotential progenitors, but it does not appear to trigger cycling of dormant stem cells.' IL-4 also supports proliferation of multipotential progenitors in much the same fashion as IL-3.2 Granulocytemacrophage colony-stimulating factor (GM-CSF) was also shown to support proliferation of a subpopulation of multipotential progenitors responding to IL-3.3 More recent studies indicate that the entry into cell cycle of the dormant stem cell is regulated by several synergistic factors. Studies of murine multipotential blast cell colonies showed that IL-64 and granulocyte-CSF ( G-CSF)5 enhance IL-3-dependent proliferation of progenitors, in part by shortening the Go period of the dormant cells. While a similar effect was observed with IL-1 in cultures of crude post-5-fluorouracil (5-FU) marrow cells$ analysis of cultures of purified human marrow cells indicated that the IL-1 effect is indirect, probably mediated in part by IL-6 and G-CSF.7
I poietic stem cells are in a quiescent state termed Go. In this state, they divide infrequently to yield actively proliferating multipotential progenitors. During regeneration from marrow aplasia, the stem cells are activated to divide more frequently. Several cytokines appear to be involved in the process of activation and regulation of the proliferation of the stem cells and their progeny. Interleukin-3 (IL-3) supports the proliferation of multipotential progenitors, but it does not appear to trigger cycling of dormant stem cells.' IL-4 also supports proliferation of multipotential progenitors in much the same fashion as IL-3.2 Granulocytemacrophage colony-stimulating factor (GM-CSF) was also shown to support proliferation of a subpopulation of multipotential progenitors responding to IL-3.3 More recent studies indicate that the entry into cell cycle of the dormant stem cell is regulated by several synergistic factors. Studies of murine multipotential blast cell colonies showed that IL-64 and granulocyte-CSF ( G-CSF)5 enhance IL-3-dependent proliferation of progenitors, in part by shortening the Go period of the dormant cells. While a similar effect was observed with IL-1 in cultures of crude post-5-fluorouracil (5-FU) marrow cells$ analysis of cultures of purified human marrow cells indicated that the IL-1 effect is indirect, probably mediated in part by IL-6 and G-CSF. 7 Recently, we identified two additional cytokines that appear to regulate the kinetics of early hematopoietic progenitors. IL-11, which was identified in medium conditioned by primate bone marrow stromal cells (PU-34): works synergistically with IL-39 and IL-4lo in support of proliferation of early progenitors by shortening their Go period. More recently, steel factor (SF) (also known as mast cell growth factor,l1 kit ligand,I2 and stem cell factor13) was shown to act synergistically with IL-3 in support of progenitor proliferation by shortening the Go period.14 Synergism in support of proliferation of multipotential progenitors was also observed between SF and IL-6 or G-CSF, but not between SF and IL-4.14 In the present study, we have examined the effects of SF and IL-11 in varying combinations with other cytokines on early hematopoietic progenitors in serum-containing and serum-free cultures. We used the bone marrow cells of 5-FU-treated mice that were serum-containing culture and the most effective two-factor combination in serum-free culture was SF plus IL-3. In serum-free cultures, three-factor combinations consisting of SF, IL-3, and one of IL-6, G-CSF, or IL-11 yielded colony formation that was comparable with that seen in serumcontaining cultures. These studies indicate that IL-1 1 belongs to a group of early-acting hematopoietic synergistic factors that now includes IL-6, G-CSF, and IL-11. In contrast, SF is unique among the synergistic factors in that it interacts either with growth factors such as IL-3 or GM-CSF or with synergistic factors such as IL-6, IL-11, or G-CSF.
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enriched about 150-fold by a combination of density gradient centrifugation and negative immunomagnetic bead selection using lineage-specific monoclonal antibodies (MoAbs). 15 We have found that IL-1 l, like IL-6 and G-CSF, acts synergistically with SF in support of multilineage colony formation with enriched bone marrow cells in serum-containing cultures. In the absence of serum, IL-3 or, less efficiently, GM-CSF, is also required.
2856
TSUJI ET AL fected with cDNA encoding murine GM-CSF. The source of IL-3 was conditioned medium of CHO cells that were engineered to produce murine IL-3 in high titer (30,000 U/mL). Recombinant human G-CSF that was expressed in E coli and recombinant human erythropoietin (Epo) were generously provided by Drs Lawrence Souza and Fu-kuen Lin of AmGen (Thousand Oaks, CA). Recombinant murine IL-4, expressed in yeast, was purified as described" and was provided by Dr Connie Flatynek of Sterling Drug Inc (Malvern, PA). Concentrations of factors in these experiments were as follows: SF, 100 ng/mL; IL-11, 100 U/mL; IL-3, 200 U/mL; GM-CSF, 200 U/mL; IL-6, 100 ng/mL; G-CSF, 100 ng/mL; and IL-4,lO ng/mL.
Methylcellulose cell cultures were established in 35-mm Lux suspension culture dishes (#5221R, Nunc, Inc, Naperville, IL). In serum-containing culture, 1 mL of culture mixture contained 500 enriched cells, a-medium (Flow Laboratories, Inc, McLean, VA), 1.2% 1,500 cp methylcellulose (Fisher Scientific Co, Norcross, GA), 1% deionized, fraction V bovine serum albumin (BSA; Sigma Chemical Co, St Louis, MO), 1 x mol/L 2-mercaptoethanol (Eastman Organic Chemicals, Rochester, NY), 30% fetal calf serum (FCS; Hyclone Laboratories, Inc, Logan, UT), 2 U/mL Epo, and designated hematopoietic factors. Because Epo was added to all cultures, the effect of one-, two-, or three-factor combinations are due, in actuality, to combinations of two, three, or four growth factors, respectively. Dishes were incubated at 37°C in a humidified atmosphere with 5% COz in air. In serum-free culture, FCS was replaced by a combination of 1% deionized crystalized BSA (Sigma Chemical Co), 600 kg/mL fully iron-saturated human transferrin ( > 98% pure) (Sigma Chemical Co), 10 kg/mL lecithin (Sigma Chemical Co), 6 +g/mL cholesterol (Sigma Chemical Co), and 1 X lo-' mol/L sodium selenite (Sigma Chemical Co); fraction V BSA was omitted. Dishes were incubated at 37°C in a humidified atmosphere with a mixture of 5% C02,5% 0 2 , and 90% N2. Except for megakaryocyte colonies, colonies consisting of 50 or more cells were scored on an inverted microscope on day 14 of incubation. Megakaryocyte colonies were scored when they contained four or more megakaryocytes. Abbreviations for colony types are as follows: GM, granulocyte/macrophage colonies; M, megakaryocyte colonies; GEM, granulocyte/erythrocyte/macrophage colonies; GMM, granulocyte/macrophage/ megakaryocyte colonies; GEMM, granulocyte/erythrocyte/macrophage/megakaryocyte colonies; and B1, blast cell colonies. Tables 2 and  3 . In serum-containing cultures (Table 2) , the overall pattern of colony formation was very similar to that reported in Table 1 with nonenriched day 2 post-5-FU marrow. However, S F and IL-11 as single agents failed to support colony formation from enriched marrow cells. The most potent two-factor combinations for multilineage colony formation were again S F plus IL-11, S F plus IL-3, SF plus IL-6, SF plus G-CSF, and 1L-11 plus IL-3. In contrast to SF, which interacted with other synergistic factors, IL-11 did not show synergism with other synergistic factors, including IL-6 and G-CSF. The combinations of IL-11 with IL-4 or GM-CSF supported a few multilineage colonies from the enriched marrow cells, although less than that observed with nonenriched cells (Table 1) .
Clonal cell culture.

RESULTS
Colony formation from nonenriched day
In serum-free cultures (Table 3) , no colony formation was observed when individual factors were tested in the presence of Epo. Formation of significant number of multilineage colonies by two-factor combinations were observed only with S F plus IL-3. Other two-factor combinations, including SF plus IL-11, supported no or few multilineage colonies.
Effects of three-factor Combinations containing SF and IL-I1 on colony formation from enriched day 2 post-5-FU marrow cells. In serum-free cultures of enriched marrow cells, combinations of S F and IL-11, S F and IL-6, and S F and G-CSF did not support multilineage colony formation G-CSF. tColony formation supported by these factor combinations is less than the colony formation supported by the factor combinations designated with (") at P < .05.
effectively (Table 3) , whereas in serum-containing cultures, these combinations effectively supported multilineage colony formation (Table 2 ). It was possible that the apparent synergism between SF and one of the synergistic factors on multilineage colony formation required additional factors in serum-free culture. Consequently, we tested three-factor Table 4 . In serum-containing cultures, addition of IL-3, IL-6, G-CSF, or GM-CSF to the combination of SF and IL-11 failed to enhance multilineage colony formation over the level supported by SF and IL-11. Addition of IL-4 to the combination of SF and IL-11 partially inhibited multilineage colony formation, possibly due to the reported negative effects of IL-4 on hematopoietic proliferation.1s In serum-free cultures, the combination of SF and IL-11 did not support formation of multilineage colonies, as already shown in Table 3 . Only when IL-3 or GM-CSF was added to the combination of SF and IL-11 were multilineage colonies obtained. The number of multilineage colonies supported by SF, IL-11, and IL-3 were comparable with serum-containing cultures. Combinations of three synergistic factors without IL-3 or GM-CSF did not effectively support multilineage colony formation. These results may indicate that FCS contains other growth factors possessing IL-3-or GM-CSF-like functions.
The observations in the serum-free cultures (Table 4 ) indicated that the combinations of SF, IL-11, and GM-CSF supported significant multilineage colony formation. In the next experiment, we tested the three-factor combinations, including SF and IL-3 or SF and GM-CSF. The results of analysis in serum-containing and serum-free cultures are presented in Table 5 . In serum-containing cultures, the combination of IL-3 and SF with either IL-11, IL-6, or G-CSF resulted in the formation of similar numbers of multilineage and total colonies. Three-factor combinations including GM-CSF and SF with either IL-11, IL-6, or G-CSF also supported formation of multilineage and total colonies. In general, cultures containing IL-3 produced more colonies than the combinations including GM-CSF, agreeing with the earlier observations that the targets of IL-3 may be at earlier stages of development than those of other factor combinations in serum-containing culture. than that in IL-3-containing cultures atP < .01.
than than in IL-hontaining cultures at P < .02.
GM-CSF?
In serum-free cultures, the order of the effectiveness of factor combinations was similar to that in serumcontaining cultures. Again, the best combinations for total and multilineage colony formation were SF and IL-3 with either IL-11, IL-6, or G-CSF. GM-CSF was less effective than IL-3 in these three-factor combinations. It was possible that the batch of FCS we used contained exceptionally high concentrations of IL-3, GM-CSF, or other proteins with similar hematopoietic functions, thereby significantly affecting our results from serum-containing cultures. To test the physiologic relevance of our studies in FCS-containing cultures, we performed the culture studies of day 2 post-5-FU marrow cells using 5% mouse plasma and compared the results with those from cultures supplemented with 5% FCS. A s shown in Table 6 , mouse plasma supported the synergistic effects of the hematopoietic growth factors on multilineage colony formation that were identical to those observed in 5% FCS culture.
Cultures in mouseplasma.
DISCUSSION
Analysis of the hematopoietic blast cell colony culture system in our laboratory has shown that the entry into cell cycle of dormant stem cells can be regulated by several combinations of cytokines, including IL-3, IL-6, G-CSF, and two more recently identified cytokines, IL-11 and SF. IL-11 was originally identified in the supernatant of cultures of nonhuman primate stromal cell line PU-34. 8 The reported biologic functions of recombinant IL-11 overlap significantly with those of IL-6, including enhancement of IL-3-dependent megakaryopoiesis in culture,19 stimulation of hepatic acute phase protein synthesis,20 and enhancement of IL-S9 and IL-4-dependentlO proliferation of multipotential progenitors in culture. SF, which was identified and its DNA cloned by investigators in several laboratories, is variously called mast cell growth factor," kit ligand,12 and stem cell factor.'* SF is encoded by the SI locus in mouse and is a ligand for c-kit, a proto-oncogene encoding a tyrosine kinase receptor.21 Mutations in the SI gene may cause severe macrocytic anemia, mast cell deficiency, hypopigmentation, and sterility in mice.22 These adverse effects on hematopoiesis caused by the mutations in the SI locus indicate that SF must play an important role in ontogeny of the hematopoietic system. Currently, a number of investigators are engaged in the characterization of the effects of SF on hematopoiesis in adult animals and there have already been a number of reports on significant effects on hematopoiesis in c u l t~r e~-~~ and in vivo.% Generally, SF appears to be a very potent synergistic factor with other cytokines. In our laboratory, we have observed that SF interacts with IL-3, IL-6, and G-CSF and enhances blast cell colony and multilineage colony formation by shortening the dormancy (Go) period of the early pr0genit0rs.l~
In this study we examined the effects of interactions between SF and IL-11 in various combinations with other early acting cytokines on the growth of early hematopoietic progenitors. We used enriched bone marrow cells from 5-FU-treated mice that had been purified about 150-fold by a combination of density gradient centrifugation and negative immunomagnetic bead selection using lineage-specific MoAbs. 15 The results indicated that SF and IL-11 interact synergistically to support proliferation of hematopoietic stem cells in serum-containing culture and that this combination was equally effective as some of the other two-or three-factor combinations. In serum-free cultures, only the combinations containing SF and IL-3 were effective in support of GEMM colony formation, in agreement with the recent observation by Migliaccio et IL-11 appears to belong to the class of hematopoietic factors that includes IL-6 and G-CSF that can function to enhance the colonysupporting abilities of combinations of IL-3 and SF or GM-CSF and SF.
These observations confirmed and extended the previous model of early hematop~iesis.~~ In this model, we proposed that IL-3 and GM-CSF are intermediate-acting growth factors regulating the survival and proliferation of actively cycling multipotential progenitors and that IL-6 and G-CSF individually can act to shorten the dormancy (Go) period of the stem cells. There is a significant overlap in the functions of these two factors and there appears to be no interaction between IL-6 and G-CSF in support of stem cell proliferation. Now we add IL-11 to this group because IL-11 interacts neither with IL-6 nor G-CSF but can interact with IL-4.l0 Although SF participates in stimulation of the cycling of dormant progenitors, several features render this factor unique; it interacts with IL-3, IL-11, IL-6, and G-CSF, but not IL-4,I4 in support of proliferation of early progenitors. It remains to be clarified how these factors interact with each other at the cellular and molecular level. Recent efforts have focused on in vivo and ex vivo manipulation of dormant hematopoietic stem cells because of the potential application in bone marrow transplantation and in treatment of therapy-induced bone marrow failure. Our results in culture indicate that useful combinations of factors for stimulation of stem cells might include SF and IL-3 along with one member of the group of synergistic factors IL-6, G-CSF, or IL-11.
